Molecular Modeling of CYP Proteins and its Implication for Personal Drug Design

Automation in Proteomics and Genomics: An Engineering Case-Based Approach

Volumn , Issue , 2009, Pages 273-292

  Wang, Jing Fang ^a   Zhang, Cheng Cheng ^a   Yan, Jing Yi ^a   Chou, Kuo Chen ^b   Wei, Dong Qing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b GORDON LIFE SCIENCE INSTITUTE   (United States)

Author keywords

Computational methods; Critical amino acids in active sites; Crystal structures of CYPs; Cytochrome P450s (CYPs); Fold recognition to supplement homology modeling; Homology modeling; Molecular modeling of CYP proteins and its implication for personal drug design; Sequence alignment technology; SWISS MODEL, MODELLER, HHpred and 3D JIGSAW

Indexed keywords

EID: 84889819563     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470741191.ch11     Document Type: Chapter

References (46)

1. Danielson, P.B. (2002) The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans. Current Drug Metabolism, 3, 561-97.
2. Hasler, J.A., Estabrook, R., Murray, M. et al. (1999) Human cytochromes P450. Molecular Aspects of Medicine, 20, 12-137.
3. Przybylski, D. and Rost, B. (2004) Improving fold recognition without folds. Journal of Molecular Biology, 341, 255-69.
4. Skolnick, J., Kihara, D. and Zhang, Y. (2004) Development and large scale benchmark testing of the PROSPECTOR 3 threading algorithm. Proteins: Structure, Function, and Bioinformatics, 56, 502-18.
5. Skolnick, J., Zhang, Y., Arakaki, A.K. et al. (2003) TOUCHSTONE: a unified approach to protein structure prediction. Proteins: Structure, Function, and Bioinformatics, 53, 411-24.
6. Ekroos, M. and Sjogren, T. (2006) Structural basis for ligand promiscuity in cytochrome P450 3A4. Proceedings of the National Academy of Sciences of the United States of America, 103, 13682-7.
7. Floudas, C.A., Fung, H.K.,McAllister, S.R. et al. (2006) Advances in protein structure prediction and de novo protein design. Chemical Engineering Science, 61, 966-88.
8. Klepeis, J.L., Floudas, C.A.,Morikis, D. et al. (2003) Integrated computational and experimental approach for lead optimization and design of compstatin variants with improved activity. Journal of the American Chemical Society, 125, 8422-3.
9. Kim, D.-H., Kim, K.-H., Isin, E.M. et al. (2008). Heterologous expression and characterization of wild-type human cytochrome P450 1A2 without conventional N-terminal modification in Escherichia coli. Protein Expression and Purification, 57, 188-200.
10. Williams, P.A., Cosme, J., Sridhar, V. et al. (2000) Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity. Molecular Cell, 5, 121-31.
11. Lewis, D.F. (2002) Modelling human cytochromes P450 involved in drug metabolism from the CYP2C5 crystallographic template. Journal of Inorganic Biochemistry, 91, 502-14.
12. Wang, J.-F., Wei, D.-Q., Li, L. et al. (2007) 3D structure modeling of cytochrome P450 2C19 and its implication for personalized drug design. Biochemical and Biophysical Research Communications, 335, 513-19.
13. Wester, M.R., Johnson, E.F., Marques-Soares, C. et al. (2003a) Structure of a substrate complex of mammalian cytochrome P450 2C5 at 2.3 A resolution: evidence for multiple substrate binding modes. Biochemistry, 42, 6370-9.
14. Wester, M.R., Johnson, E.F., Marques-Soares, C. et al. (2003b) Structure of mammalian cytochrome P450 2C5 complexed with diclofenac at 2.1 A resolution: evidence for an induced fit model of substrate binding. Biochemistry, 42, 9335-45.
15. Schoch, G.A., Yano, J.K.,Wester, M.R. et al. (2004) Structure of humanmicrosomal cytochrome P450 2C8. Evidence for a peripheral fatty acid binding site. Journal of Biological Chemistry, 279, 9497-503.
16. Williams, P.A., Cosme, J., Ward, A. et al. (2003) Crystal structure of human cytochrome P450 2C9 with bound warfarin. Nature, 424, 464-8.
17. Wester, M.R., Yano, J.K., Schoch, G.A. et al. (2004) The structure of human cytochrome P450 2C9 complexed with flurbiprofen at 2.0-A resolution. Journal of Biological Chemistry, 279, 35630-7.
18. Rowland, P., Blaney, F.E., Smyth, M.G. et al. (2006) Crystal structure of human cytochrome P450 2D6. Journal of Biological Chemistry, 281, 7614-22.
19. Yano, J.K., Wester, M.R., Schoch, G.A. et al. (2004) The structure of human microsomal cytochrome P450 3A4 determined by X-ray crystallography to 2.05-A resolution. Journal of Biological Chemistry, 279, 38091-4.
20. Williams, P.A., Cosme, J., Vinkovic, D.M. et al. (2004) Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone. Science, 305, 683-6.
21. Scott, E.E.,White, M.A., He, Y.-A. et al. (2004) Structure of mammalian cytochrome P450 2B4 complexed with 3-(4-chlorophenyl)imidazole at 1.9 A resolution: insight into the range of P450 conformations and the coordination of redox partner binding. Journal of Biological Chemistry, 279, 27294-301.
22. Zhao, Y.-H., White, M.A., Muralidhara, B.K. et al. (2006) Structure of microsomal cytochrome P450 2B4 complexed with the antifungal drug bifonazole: insight into P450 conformational plasticity and membrane interaction. Journal of Biological Chemistry, 281, 5973-81.
23. Zhao,Y.-H., Sun, L.,Muralidhara,B.K. et al. (2007) Structural and thermodynamic consequences of 1-(4-chlorophenyl)imidazole binding to cytochrome P450 2B4. Biochemistry, 46, 11559-67.
24. Yano, J.K., Hsu, M.-H., Griffin, K.J. et al. (2005) Structures of human microsomal cytochrome P450 2A6 complexed with coumarin and methoxsalen. Nature Structural and Molecular Biology, 12, 822-3.
25. Yano, J.K., Deton, T.T., Cerny,M.A. et al. (2006) Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization. Journal of Medicinal Chemistry, 49, 6987-7001.
26. Sansen, S., Hsu, M.-H., Stout, C.D. and Johnson, E.F. (2007a) Structural insight into the altered substrate specificity of human cytochrome P450 2A6 mutants. Archives of Biochemistry and Biophysics, 464, 197-206.
27. Sansen, S., Yano, J.K., Reynald, R.L. et al. (2007b) Adaptations for the oxidation of polycyclic aromatic hydrocarbons exhibited by the structure of human P450 1A2. Journal of Biological Chemistry, 282, 14348-55.
28. Orengo, C.A., Michie, A.D., Jones, S. et al. (1997) CATH: a hierarchic classification of protein domain structures. Structure, 5, 1093-108.
29. Otyepka,M., Skopalik, J., Anzenbacherova, E. andAnzenbacher, P. (2007).What common structural features and variations of mammalian P450s are known to date. Biochimica et Biophysica Acta, 1770, 376-89.
30. Kemper, B. (2004) Structural basis for the role in protein folding of conserved proline-rich regions in cytochromes P450. Toxicology and Applied Pharmacology, 199, 305-15.
31. Mestres, J. (2005) Structure conservation in cytochromes P450. Proteins: Structure, Function, and Bioinformatics, 58, 596-609.
32. Hudecek, J., Anzenbacherova, E., Anzenbacher, P. et al. (2000) Structural similarities and differences of the heme pockets of various P450 isoforms as revealed by resonance Raman spectroscopy. Archives of Biochemistry and Biophysics, 383, 70-8.
33. Tsiftsoglou, A.S., Tsamadou, A.I. and Papadopoulou, L.C. (2006) Heme as key regulator of major mammalian cellular functions:Molecular, cellular, and pharmacological aspects. Pharmacology and Therapeutics, 111, 327-45.
34. Poulos, T.L. (2005) Structural biology of heme monooxygenases. Biochemical and Biophysical Research Communications, 338, 337-45.
35. Munro, A.W., Girvan, H.M. and McLean, K.J. (2007) Cytochrome P450: redox partner fusion enzymes. Biochimica et Biophysica Acta, 1770, 345-59.
36. Hannemann, F., Bichet, A., Ewen, K.M. and Bernhardt, R. (2007) Cytochrome P450 systems: biological variations of electron transport chains. Biochimica et Biophysica Acta, 1770, 330-44.
37. Anzenbacher, P. and Anzenbacherová, E. (2001) Cytochromes P450 and metabolism of xenobiotics. Cellular and Molecular Life Sciences, 58, 737-47.
38. Rendic, S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metabolism Reviews, 34, 83-448.
39. Dabrowski, M.J., Schrag, M.L., Wienkers, L.C. and Atkins, W.M. (2002) Pyrene-pyrene complexes at the active site of cytochrome P450 3A4: evidence for a multiple substrate binding site. Journal of the American Chemical Society, 124, 11866-7.
40. Schrag,M.L. andWienkers, L.C. (2001) Covalent alteration of the CYP3A4 active site: evidence for multiple substrate binding domains. Archives of Biochemistry and Biophysics, 391, 49-55.
41. Scott, E.E. and Halpert, J.R. (2005) Structures of cytochrome P450 3A4. Trends in Biochemical Sciences, 30, 5-7.
42. Kirton, S.B.,Murray, C.W., Verdonk, M.L. and Taylor, R.D. (2005) Prediction of binding modes for ligands in the cytochromes P450 and other heme-containing proteins. Proteins: Structure, Function, and Bioinformatics, 58, 836-44.
43. Lewis, D.F., Jacobs, M.N. and Dickins, M. (2004) Compound lipophilicity for substrate binding to human P450s in drug metabolism. Drug Discovery Today, 9, 530-7.
44. Waterschoot, R.A.V., Keizers, P.H., Graaf, C.D. et al. (2006) Topological role of cytochrome P450 2D6 active site residues. Archives of Biochemistry and Biophysics, 447, 53-8.
45. Marechal, J.D., Kemp, C.A., Roberts, G.C.K. et al. (2008) Insights into drug metabolism by cytochromes P450 from modeling studies of CYP2D6-drug interactions. British Journal of Pharmacology, 153, S82-9.
46. Wang, J.-F., Wei, D.-Q., Chen, C. et al. (2008) Molecular modeling of two CYP2C19 SNPs and its implications for personalized drug design. Protein and Peptide Letters, 15, 27-32.